NCT03076203 2025-04-29Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)Thomas Jefferson UniversityPhase 1 Completed14 enrolled
NCT02507570 2019-03-19Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone MetastasisCarolina Research Professionals, LLCPhase 2 Completed40 enrolled